tiprankstipranks
Advertisement
Advertisement

AU:COV Stock Latest News

Cleo Diagnostics Director Exercises 1.5 Million Options to Increase Shareholding
Company AnnouncementsCleo Diagnostics Director Exercises 1.5 Million Options to Increase Shareholding
17d ago
COV
Cleo Diagnostics Issues New Shares Under Regulatory Exemption
PremiumCompany Announcements
Cleo Diagnostics Issues New Shares Under Regulatory Exemption
17d ago
COV
CLEO Diagnostics Seeks ASX Quotation for 5.27 Million New Shares
PremiumCompany Announcements
CLEO Diagnostics Seeks ASX Quotation for 5.27 Million New Shares
17d ago
COV
CLEO Diagnostics Options Lapse, Simplifying Capital Structure
PremiumCompany Announcements
CLEO Diagnostics Options Lapse, Simplifying Capital Structure
17d ago
COV
Cleo Diagnostics Director Restructures Holding via Super Fund Transfer
PremiumCompany Announcements
Cleo Diagnostics Director Restructures Holding via Super Fund Transfer
20d ago
COV
Cleo Diagnostics Updates ASX Corporate Governance Disclosures
PremiumCompany AnnouncementsCleo Diagnostics Updates ASX Corporate Governance Disclosures
21d ago
COV
Cleo Diagnostics Posts Deeper Annual Loss as Revenue Falls and Asset Backing Weakens
Premium
Company Announcements
Cleo Diagnostics Posts Deeper Annual Loss as Revenue Falls and Asset Backing Weakens
21d ago
COV
Cleo Diagnostics advances U.S. FDA pathway for ovarian cancer blood test
Premium
Company Announcements
Cleo Diagnostics advances U.S. FDA pathway for ovarian cancer blood test
1M ago
COV
Cleo Diagnostics Begins Analytical Validation Ahead of Planned FDA 510(k) Bid
PremiumCompany Announcements
Cleo Diagnostics Begins Analytical Validation Ahead of Planned FDA 510(k) Bid
2M ago
COV
CLEO Diagnostics Director Restructures Holding of Unlisted Options
PremiumCompany Announcements
CLEO Diagnostics Director Restructures Holding of Unlisted Options
2M ago
COV
Cleo Diagnostics Issues 250,000 New Shares Under Corporations Act Exemption
PremiumCompany Announcements
Cleo Diagnostics Issues 250,000 New Shares Under Corporations Act Exemption
3M ago
COV
CLEO Diagnostics Seeks Quotation for Additional ASX Shares
PremiumCompany Announcements
CLEO Diagnostics Seeks Quotation for Additional ASX Shares
3M ago
COV
Cleo Diagnostics Hits Key U.S. Trial Milestone and Locks In Platform for Ovarian Cancer Test
PremiumCompany AnnouncementsCleo Diagnostics Hits Key U.S. Trial Milestone and Locks In Platform for Ovarian Cancer Test
4M ago
COV
Cleo Diagnostics Starts Staged Manufacturing of Ovarian Cancer Test Kits with Bio-Techne
Premium
Company Announcements
Cleo Diagnostics Starts Staged Manufacturing of Ovarian Cancer Test Kits with Bio-Techne
5M ago
COV
Cleo Diagnostics Hits Key U.S. Trial Milestone for Ovarian Cancer Test
Premium
Company Announcements
Cleo Diagnostics Hits Key U.S. Trial Milestone for Ovarian Cancer Test
5M ago
COV
Cleo Diagnostics Finalises Enhanced Biomarker Panel Ahead of FDA Push
PremiumCompany Announcements
Cleo Diagnostics Finalises Enhanced Biomarker Panel Ahead of FDA Push
6M ago
COV
Cleo Diagnostics Narrows Asset Gap as Loss Widens on Lower Revenue
PremiumCompany Announcements
Cleo Diagnostics Narrows Asset Gap as Loss Widens on Lower Revenue
7M ago
COV
Cleo Diagnostics Expands U.S. Ovarian Cancer Market Opportunity as Trial Nears Key Milestone
PremiumCompany Announcements
Cleo Diagnostics Expands U.S. Ovarian Cancer Market Opportunity as Trial Nears Key Milestone
7M ago
COV
Hudson Institute Investment Holdings Ceases to Be Substantial Holder in CLEO Diagnostics
PremiumCompany Announcements
Hudson Institute Investment Holdings Ceases to Be Substantial Holder in CLEO Diagnostics
8M ago
COV
Cleo Diagnostics Flags Pivotal 2026 After Key Progress on Ovarian Cancer Test
PremiumCompany AnnouncementsCleo Diagnostics Flags Pivotal 2026 After Key Progress on Ovarian Cancer Test
8M ago
COV
Cleo Diagnostics Issues Over 8.3 Million New Shares Without Prospectus
Premium
Company Announcements
Cleo Diagnostics Issues Over 8.3 Million New Shares Without Prospectus
8M ago
COV
CLEO Diagnostics Issues 833,333 Unquoted Options Under Existing Capital Plan
Premium
Company Announcements
CLEO Diagnostics Issues 833,333 Unquoted Options Under Existing Capital Plan
8M ago
COV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >